Role of AIF in caspase-dependent and caspase-independent cell death

• Published in: Oncogene Vol. 23; no. 16; pp. 2785 - 2796
• Main Authors: Cregan, Sean P, Dawson, Valina L, Slack, Ruth S
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 12-04-2004
• Subjects: Animals; Apoptosis; Apoptosis Inducing Factor; Caspase; Caspases - physiology; Cell death; Cerebral infarction; Chemotherapy; Endonuclease; Flavoproteins - physiology; Humans; Membrane Proteins - physiology; Mitochondria; Mitochondria - physiology; Myocardial infarction; Neurodegenerative diseases; p53 Protein; Poly(ADP-ribose); Poly(ADP-ribose) polymerase; Poly(ADP-ribose) Polymerases - physiology; Ribose; Signal transduction; Therapeutic targets; Tumor cells
• ISSN: 0950-9232; 1476-5594
• DOI: 10.1038/sj.onc.1207517

The major challenge in treating cancer is that many tumor cells carry mutations in key apoptotic genes such as p53, Bcl family proteins or those affecting caspase signaling. Such defects render treatment with traditional chemotherapeutic agents ineffective. Many studies have demonstrated the importance of caspase-independent cell death pathways in injury, degenerative diseases and tumor tissue. It is now recognized that in addition to their critical role in the production of cellular energy, mitochondria are also the source of key proapoptotic molecules involved in caspase activation. More recently, it has been discovered that in response to apoptotic stimuli, mitochondria can also release caspase-independent cell death effectors such as AIF and Endonuclease G. In this review, we examine the role of Bcl family proteins and poly(ADP-ribose) polymerase-1 signaling in the regulation of these apoptotic pathways and address the ongoing controversies in this field. Continued study of the mechanisms of apoptosis including caspase-independent death processes are likely to reveal novel therapeutic targets for the treatment of diverse human pathologies including cancer, neurodegenerative diseases and acute injuries such as stroke or myocardial infarction.